What did EMA achieve in 2025 - and what’s next? Our Executive Director, Emer Cooke, shares the vision: a faster path from innovation to safe #medicines. In 2026 we focus on reimagining EMA, innovation & people. Read more 👇 www.ema.europa.eu/en/news/emer... #medsky #health

🦠 As #AntimicrobialResistance grows, phage therapy could represent an alternative to antibiotics. A recent article, co-authored by EMA experts, examines the scientific, industrial, and regulatory barriers, and opportunities for treatment development and international collaboration. bit.ly/3XXgMTT

How do we prepare for the next pandemic? New podcast episode features EMA’s Head of Public Health Threats, Marco Cavaleri, on COVID-19 lessons & future readiness. Watch here:

📢 EMA recommends: 7 new medicines 💊 for approval, including 1 medicine to treat #BladderCancer and an extension of indication of a #GLP1 medicine to treat adolescents and children with type II diabetes #PublicHealth #medsky 👇 www.ema.europa.eu/en/news/meet...

Historic day for EU medicines! EMA welcomes political agreement on new pharmaceutical legislation – the biggest reform in 20+ years. 👉 Faster patient access 👉 Stronger supply security 👉 More support for innovation 📖 Learn more: www.ema.europa.eu/en/news/ema-...

Medicine shortages are a serious public health concern that can affect anyone. We partnered with healthcare professionals to show how collaboration supports patient health👇 Check out the full campaign here: www.ema.europa.eu/en/human-reg... #ittakesateam

📣 New data on antimicrobials sales and their use in animals in the EU We just published the second European Sales and Use of Antimicrobials for Veterinary Medicine (ESUAvet). Check out the report and the new interactive dashboard 👇 www.ema.europa.eu/en/news/new-...

Live on 15 Dec, 9:00 CET, multistakeholder workshop on Alzheimer’s patient registries. For registry holders, patients, regulators, pharma, clinicians, researchers, HTAs & payers to shape stronger evidence on medicine safety & effectiveness. Watch the livestream 👇 www.ema.europa.eu/en/events/jo...

Medicine shortages can affect radiopharmaceuticals used in everyday care. As part of our shortages campaign, we talked to EANM about strengthening production networks to ensure access to medicines 👇 Check out the full campaign here: www.ema.europa.eu/en/human-reg... #ittakesateam

Our safety committee, the #PRAC, has just concluded its November meeting. PRAC responsibilities cover all aspects of the risk management of the use of medicines. Find out more in the PRAC highlights: www.ema.europa.eu/en/news/meet...

In 2022, there were 1 million fewer animal uses in medicines testing compared with 2015. EMA’s 2023–24 3R Working Party report shows how science and animal welfare can go hand in hand. Find out more: www.ema.europa.eu/en/human-reg...

During #medicineshortages, #GPs prescribe alternative treatments and medical oversight for patients. Teamwork in action with @UEMO 👇 Check out the full campaign here: www.ema.europa.eu/en/human-reg... #ittakesateam

Join us at the HMA/EMA Annual Data Forum 2025 to shape the future of data-driven medicines regulation in the EU! 📅 9 Dec 2025 📍 Amsterdam & Virtual Shape the next chapter. Register now: www.ema.europa.eu/en/events/em... #MedicinesRegulation #DataScience

It’s World Antimicrobial Awareness Week! AMR could cause over 8.2M deaths yearly by 2050. It threatens health systems, economies, food safety & global security. Medicines regulators worldwide are united in tackling AMR. Now is the time to act—protect today, secure tomorrow.

🎙 New podcast just dropped! With Inside EMA we take you behind the scenes of medicines regulation in the EU. Episode 1 is all about antimicrobial resistance—a major global health threat. Hear from our experts on how we’re tackling it. 🎧 Watch here: youtu.be/MlNDrUotltg?...

#Hospitalpharmacists keep patients safe when #shortages hit - managing supplies, prioritising urgent patients, and choose safe alternatives. Co-created with @EAHP 👇 Check out the full campaign here: www.ema.europa.eu/en/human-reg... #ittakesateam

New approach to accelerate the development of medicines and vaccines for public health threats like #AMR Improved scientific advice will speed up approvals and strengthen Europe’s preparedness. Learn more 👉 www.ema.europa.eu/en/news/impr...

📢 EMA recommends 10 new medicines 💊 for approval, including a first-in-class treatment to delay onset of type1 #diabetes and 2 medicines to treat #cancer. Read more 👉 www.ema.europa.eu/en/news/meet... #PublicHealth #MedSky

#Pharmacists help track #medicinesshortages, find alternatives, and reassure patients. Co-created with @PGEU 👇 Check out the full campaign here: www.ema.europa.eu/en/human-reg... #ittakesateam

🌍💊 It’s #MedSafetyWeek 2025! EMA and partners worldwide are promoting medicine safety and encouraging everyone to report suspected side effects. 🔍 Find out how the EU system works to keep medicines safe.: www.ema.europa.eu/en/about-us/... #MedSky

💊 New booklet: “From laboratory to patients - How the safety of medicines is ensured in the European Union” Published for #MedicineSafetyWeek — explore how EMA & EU countries work together to keep medicines safe and safeguard the health of patients. 👉 www.ema.europa.eu/en/about-us/...

The HMA/EMA multi-stakeholder workshop on AI is coming up on 20–21 Nov! Join us for updates on AI regulation, HMA/EMA activities, and real-world AI use cases across the medicines lifecycle. Learn more about the livestream info & agenda: www.ema.europa.eu/en/events/hm...

#Medicineshortages affect us all, from painkillers to life-saving treatments. #EMA and partners work together to prevent and manage them across Europe. Watch the first video of the new campaign 👇 youtu.be/o9z0y8eHQYM?... #ittakesateam

On World One Health Day we are partnering with agencies across the EU and beyond to reaffirm our commitment, working across sectors, disciplines and borders, recognising the link between human, animal, and environmental health. Read the joint statement below www.ema.europa.eu/en/partners-...

Our safety committee, the PRAC, has just agreed on a communication for healthcare professionals concerning the use of injectable tranexamic acid. Read more: www.ema.europa.eu/en/news/meet...

One big highlight from today’s ACT EU annual meeting: the launch of the first EU-wide clinical trials map 🌍 Now available in all EU/EEA languages, making trials easier to find and join. Explore the map 👉 euclinicaltrials.eu/search-for-c...

📢 New reflection paper on using non-human primates (NHPs) in medicine safety testing now open for consultation. A key step toward major reduction in NHP use. Have your say until 31 January 2026: www.ema.europa.eu/en/non-human...

📣 EMA launches its 1st campaign with content creators to promote safe and responsible use of GLP-1 medicines. The aim is to cut through the hype & #disinformation around weight loss treatments. #HealthNotHype 💊✅ Learn more: www.ema.europa.eu/en/news/ema-... #medsky

📢 EMA recommends 2 new medicines 💊 for approval: ☑️ The first treatment for non-cystic fibrosis #bronchiectasis ☑️ 1 medicine to treat persistent or chronic immune #thrombocytopenia Check out the highlights 👇 www.ema.europa.eu/en/news/meet... More on bronchiectasis 👇 www.ema.europa.eu/en/news/firs...

💡 New joint article from European Association of Urology & EMA! Published in European Urology, it calls for responsible #fluoroquinolone prescribing. Close teamwork is key to patient safety and overcoming challenges in clinical practice. Read more: www.europeanurology.com/article/S030... #MedSky

EMA's October 2025 Management Board highlights are now available. The Board noted EMA's mid-year report and endorsed the first data strategy for the European medicines regulatory network. Read more here 👉https://www.ema.europa.eu/en/news/ema-management-board-highlights-october-2025-meeting

Our safety committee, the #PRAC, has just concluded its October meeting. PRAC responsibilities cover all aspects of the risk management of the use of medicines. Find out more in the PRAC highlights: www.ema.europa.eu/en/news/meet...

New from the @eea.europa.eu 👉 The State of the Environment 2025 assessment. A stark reminder of the #OneHealth connection. Chemical pollution, AMR, & biodiversity loss directly impact medicine efficacy, disease emergence, and public health. #EuropesEnvironment2025 www.eea.europa.eu/en/newsroom/...

📢 EMA’s first reflection paper on Patient Experience Data is out! Provide feedback and help shape how patient voices are used in medicine regulation. 🗓️ Deadline: 31 Jan 2026 🔗https://www.ema.europa.eu/en/news/path-better-include-patients-perspectives-regulation-medicines #MedSky

EDQM joins an EU initiative with EMA to strengthen medicines regulation across Sub-Saharan Africa 🌍. This means boosting lab networks and supporting the African Medicines Agency. A big step for access to safe, quality medicines. www.ema.europa.eu/en/partners-... #TeamEurope #GlobalHealth

With the European Commission and the Heads of Medicines Agencies, we have set new targets to make the EU a top destination for #clinicaltrials and speed up patient access to innovative #medicines. 👉 Learn what these targets are: www.ema.europa.eu/en/news/new-... #MedSky

Paracetamol remains an important option to treat pain or fever in pregnant women. Following rigorous assessment of the available scientific data, we find no evidence that taking paracetamol during pregnancy causes autism in children. Read more 👉 www.ema.europa.eu/en/news/use-...

Meet the #EHFG2025 speakers ⬇️ We are thrilled to welcome Emer Cooke, Executive Director of @ema.europa.eu, to our first plenary: 🤝 Rethinking solidarity in health: healing Europe's fractured social contract 🗓 1 October | 14:30-15:45 CET 💻 Register to join in person or online 👉 bit.ly/4prNqJR

New EU variations guidelines! They'll streamline how marketing authorisations of medicines are modified and updated, making the process faster for regulators & marketing authorisation holders. Meaning quicker access to improved treatments for patients across Europe. www.ema.europa.eu/en/news/new-...

📢 EMA recommends 14 new medicines 💊 for approval, including: ☑️ 1 medicine for respiratory syncytial virus #RSV ☑️ 1 medicine to treat vasomotor symptoms associated with #Menopause ☑️ 1 medicine to treat #Diabetestype2 www.ema.europa.eu/en/news/meet... #PublicHealth

Together with many European medicines authorities, we’re joining the campaign #medicinesarenotsweets🍬 Make sure you use over-the-counter medicines safely. They may be easy to buy, but they are not candy. Find out more about the campaign: www.hma.eu/about-hma/re...

EMA starts a review of medicines containing #levamisole, used to treat parasitic worm infections, to assess the risk of leukoencephalopathy, a condition affecting the brain. Find out more in the #PRAC highlights 🔍 www.ema.europa.eu/en/news/meet...

Flea and tick treatments for cats and dogs may have a bigger #environmental impact than previously thought. EMA seeks input for development of a new environmental risk assessment guideline for #veterinary #medicines used to control external parasites. www.ema.europa.eu/en/methodolo... #medsky

🚨 Warning: Sharp rise in illegal sales of GLP-1 medicines in the EU 🚨 Find out how to protect your health from dangerous offers: 🔗 www.ema.europa.eu/en/news/warn...

Today EMA and WHO mark 10 years of collaboration to enhance global health. We work together to help ensure people have access to safe, effective and high-quality medicines all over the world. Check out this overview of our key joint initiatives: www.ema.europa.eu/en/news/ema-...

Are you using #finasteride tablets for hair loss? Our safety committee confirmed suicidal thoughts as #sideeffect of these medicines and issued recommendations for #patients and healthcare professionals. Watch and read more - www.youtube.com/watch?v=8Vhf... #MedSky

📣 Call for expression of interest: Join EMA's first Scientific Advisory Group on Immune and Inflammatory Diseases. Mandate duration: 3 years, upon the Committee for Medicinal Products for Human Use (CHMP) appointment. Find out more now 👉 lnkd.in/eXXHv5nb

Not long ago, we interviewed Bart Van der Schueren, EMA expert and obesity specialist, to discuss some of the common questions around #GLP1 receptor agonists. One of the takeaways: GLP-1s are not an easy solution for weight loss 🚫 Watch the full interview now on YouTube: lnkd.in/dHjrTwFv

Have you ever wondered how medicines are named? Watch this video to find out! 📹 EMA plays a crucial role in approving the names of all medicines in the EU. Clear and accurate naming is crucial for patient safety and effective healthcare delivery. #EMA #MedSky #PublichHealth #Medicines

EMA recommends 13 new medicines for approval: ☑️ 1 medicine for #HIV-1 pre-exposure prophylaxis #PrEP to be taken twice a year ☑️ 1 medicine to treat patients with #Niemann-Pick type C ☑️ 1 medicine to be taken orally to treat hereditary angioedema #HAE www.ema.europa.eu/en/news/meet... #PublicHealth